Motive Wealth Advisors Maravai Lifesciences Holdings, Inc. Transaction History

Motive Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$26.05 - $37.48 $2,005 - $2,885	-77 Reduced 0.34%	22,384 $636,000
Q1 2022 May 03, 2022	SELL	$24.46 - $40.92 $36,592 - $61,216	-1,496 Reduced 6.24%	22,461 $792,000
Q4 2021 Feb 08, 2022	BUY	$35.0 - $45.94 $303,625 - $398,529	8,675 Added 56.77%	23,957 $1 Million
Q3 2021 Nov 16, 2021	BUY	$36.8 - $60.62 $289,248 - $476,473	7,860 Added 105.9%	15,282 $750,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $240,918 - $333,990	7,422 New	7,422 $310,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Motive Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Motive Wealth Advisors with notifications on news.